¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"fibrinolytic activity"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É, ÇǺ기¿ëÇØ´É
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrinolytic
    ¼¶À¯¼Ò¿ëÇØ-, ÇǺ기¿ëÇØ-
  • fibrinolytic agent
    ¼¶À¯¼Ò¿ëÇØÁ¦, ÇǺ기¿ëÇØÁ¦
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò, ÇǺ기¿ëÇØÈ¿¼Ò
  • antibacterial activity
    Ç×±ÕÀÛ¿ë
  • activity
    1. Ȱ¼ºµµ 2. Ȱµ¿, Ȱ¼º 3. -´É
  • biologic activity
    »ý¹°ÇÐÀûȰ¼º
  • caries activity
    ¿ì½ÄȰµ¿
  • electrical activity
    Àü±âȰ¼º
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • helper cell activity
    µµ¿ò¼¼Æ÷Ȱ¼º
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÇàÀ§
  • involuntary activity
    ºÒ¼öÀÇȰµ¿
  • insertion activity
    »ðÀÔȰµ¿ÀüÀ§
  • insulin-like activity
    Àν¶¸°À¯»çȰ¼ºµµ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ, Ȱµ¿
  • specific activity
    ºñ¹æ»ç´É, ƯÀÌȰ¼ºµµ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrinolytic agent
    ¼¶À¯¼Ò¿ëÇØ¹°Áú
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò
  • fibrinolytic
    ¼¶À¯¼Ò¿ëÇØ-
  • activity
    Ȱ¼ºµµ, Ȱµ¿
  • activity therapist
    Ȱµ¿¿ä¹ý»ç, Ȱµ¿Ä¡·á»ç
  • activity therapy
    Ȱµ¿¿ä¹ý
  • antibacterial activity
    Ç×±ÕÀÛ¿ë
  • caries activity
    ¿ì½ÄȰµ¿¼º
  • electrical activity
    Àü±âȰµ¿
  • enzyme activity
    È¿¼ÒȰ¼º, È¿¼ÒȰ¼ºµµ
  • helper cell activity
    µµ¿ò¼¼Æ÷´É, Á¶·Â¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
  • homosexual activity
    µ¿¼º¾ÖÇàÀ§
  • insertion activity
    »ðÀÔȰµ¿ÀüÀ§
  • integrated neural activity
    ÅëÇսŰæÈ°¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Fibrinolytic system
    ¼¶À¯¼Ò¿ëÇØ°è(¡­Ìõ)
  • SAR : structure activity relationship
    ±¸Á¶ÀÛ¿ë°ü°è.
  • activity
    Ȱ¼ºµµ(üÀàõöô), Ȱµ¿µµ(üÀÔÑöô), Ȱ¼º(üÀàõ).
  • activity
    ¹æ»ç´É, Ȱ¼ºµµ
  • activity therapist
    Ȱµ¿ ¿ä¹ý»ç
  • activity therapy
    Ȱµ¿¿ä¹ý(¡­èþÛö).
  • activity therapy
    Ȱµ¿ ¿ä¹ý
  • activity, antibacterial
    Ç×±ÕÀÛ¿ë
  • amylase activity
    ¾Æ¹Ð¶óÁ¦-Ȱ¼ºµµ
  • antibacterial activity
    Ç×±ÕÀÛ¿ë(ù÷жíÂéÄ), Ç×±ÕȰ¼º(ù÷жüÀàõ).
  • functional activity
    ±â´É¼º Ȱ¼ºµµ<Ȱµ¿µµ>
  • fusion activity
    À¶ÇÕ´É
  • glucagon activity
    ±Û·çÄ«°ïȰ¼ºµµ.
  • helper cell activity
    Á¶·Â¼¼Æ÷´É, º¸Á¶¼¼Æ÷´É
  • hemolytic activity
    ¿ëÇ÷´É
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • fibrinolytic activity
    ¼¶À¯¼Ò¿ëÇØ´É
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • coagulation,fibrinolytic system
    ¼¶À¯¼Ò ¿ëÇØ°è(àéë«áÈéÁú°Í§)
  • fibrinolytic
    ¼¶À¯¼Ò¿ëÇØÀÇ.
  • fibrinolytic agent
    ¼¶À¯¼Ò¿ëÇØ¼º ¹°Áú.
  • fibrinolytic enzyme
    ¼¶À¯¼Ò¿ëÇØÈ¿¼Ò.
  • fibrinolytic system
    ¼¶À¯¼Ò¿ëÇØ°è(éÁú°Í§)
  • activity
    ¹æ»ç´É, Ȱ¼ºµµ
  • activity
    Ȱ¼ºµµ(üÀàõöô), Ȱµ¿µµ(üÀÔÑöô), Ȱ¼º(üÀàõ).
  • activity therapist
    Ȱµ¿ ¿ä¹ý»ç
  • activity therapy
    Ȱµ¿ ¿ä¹ý
  • activity therapy
    Ȱµ¿¿ä¹ý(¡­èþÛö).
  • activity, antibacterial
    Ç×±ÕÀÛ¿ë
  • amylase activity
    ¾Æ¹Ð¶óÁ¦-Ȱ¼ºµµ
  • antibacterial activity
    Ç×±ÕÀÛ¿ë(ù÷жíÂéÄ), Ç×±ÕȰ¼º(ù÷жüÀàõ).
  • bacteri(o)cidal activity
    »ì±Õ·Â.
  • binding activity
    °áÇÕȰ¼º(Ì¿ùêüÀàõ).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ·®(üÀÕá)
  • activity
    Ȱ¼º (üÀàõ)
  • activity coefficient
    Ȱ·®°è¼ö (üÀÕá°èâ¦)
  • catalytic center activity
    Ã˸ÅÁß½É È°¼º(õºØÚñéãýüÀàõ)
  • concentration of enzymatic activity
    È¿¼ÒȰ¼º ³óµµ(ý£áÈüÀàõÒØÓø)
  • enzymatic activity
    È¿¼Ò Ȱ¼º (ý£áÈüÀàõ)
  • intrinsic activity
    ³»ÀçȰ¼º(Ò®î¤üÀàõ)
  • mean activity coefficient
    Æò±ÕȰµ¿°è¼ö(øÁгüÀÔÑͪâ¦)
  • mean ionic activity coefficient
    Æò±Õ(øÁг) ÀÌ¿ÂȰ¼º°è¼ö(üÀàõͪâ¦)
  • molar activity
    ¸ô Ȱ¼º(üÀàõ)
  • molecular activity
    ºÐÀÚȰ¼º(ÝÂí­üÀàõ)
  • myotropic activity
    ±Ù°­È­È°¼º(ÐÉË­ûùüÀàõ)
  • optical activity
    ±¤ÇРȰ¼º(ÎÃùÊüÀàõ)
  • Raman optical activity
    ¶ó¸¸ ±¤ÇРȰ¼º(µµ)(ÎÃùÊüÀàõ(Óø))
  • relative specific activity
    »ó´ë ƯÀÌ È°¼ºµµ(ßÓÓß÷åì¶üÀàõÓø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱ¼ºµµ, Ȱµ¿µµ
  • fibrinolytic
    ¼¶À¯¼Ò¿ëÇØÀÇ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FA false aneurysm; Families Anonymous; Fanconi anemia; far advanced; fatty acid; febrile antigen; femor...
NYHA New York Heart Association
  Heart Disease¿¡ ´ëÇÑ Functional Classification
 &nbs...
SFA saturated fatty acid; seminal fluid assay; serum folic acid; stimulated fibrinolytic activity; super...
FDP(s)   1) Fibrinolytic split Products(= FSP)
  2) Fibrinogen Degradation Products
IIFT itraoperative intraarterial fibrinolytic therapy
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
EFA Euglobulin Fibrinolytic Activity
FA Fibrinolytic activity
AChE Acetylcholinesterase activity
ABC Activity Based Costing
AI Activity Index
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • fibrinolytic
    ÆÄÀ̺기 ¿ëÇØ¼ºÀÇ
    È¿¼Ò¿¡ ÀÇÇÑ ÆÄÀ̺기ÀÇ ¿ëÇØ¿¡ °üÇÑ, ¿ëÇØ¸¦ ÀÏÀ¸Å°´Â.
  • fibrinolytic purpura
    ¼¶À¯¼Ò ¿ëÇØ¼º ÀÚ¹Ý
    µ¿ÀǾî=
  • activity
    Ȱ¼ºµµ, Ȱµ¿µµ
    1. Ȱ¼ºÈ­µÈ »óÅÂ. ¾î¶² È¿°ú¸¦ ¾òÀ» ¼ö ÀÖ´Â ´É·Â. ¾î¶² ÀÛ¿ë ¶Ç´Â ±â´ÉÀÇ ¿¬Àå. 2. ºñÀÌ»óÀûÀÎ ¿ë¾×¿¡¼­ È¿°úÀûÀÎ ³óµµ¸¦ ³ªÅ¸³¾ ¼ö ÀÖ´Â ¿­¿ªÇÐÀûÀÎ ¾ç. ¸¸¾à ³óµµ°¡ Ȱµ¿µµ·Î ´ëü µÈ´Ù¸é ÆòÇü»ó¼ö¿¡ °üÇÑ ¹æÁ¤½Ä, ÀüÀ§, »ïÅõ¾Ð, ²ú´Â Á¡ ¿À¸§, ¾î´Â Á¡ ³»¸², Èֹ߼º ¿ëÁúÀÇ Áõ±â¾ÐÀº Èñ¼® ¿ë¾×¿¡¼­ ¸ðµç ³óµµ¿¡ ´ëÇØ °íÁ¤µÈ Á¤È®ÇÑ ¹æÁ¤½ÄÀÇ ±Ù»ç °ªÀ¸·Î ¹Ù²î¾î Áø´Ù. Ȱµ¿µµ´Â ºñÀÌ»óÀûÀÎ °ÍÀ¸·ÎºÎÅÍ ÃøÁ¤µÈ ºÎÇǰ¡ ¾ø´Â ¼ýÀÚ, Ȱµ¿°è¼ö¿Í »ý»ê¹°ÀÇ ³óµµ¿Í °°´Ù.
  • activity index
    Ȱµ¿ Áö¼ö
  • antibacterial activity
    Ç×±Õ ÀÛ¿ë
  • binding activity
    °áÇÕ È°¼º
  • bone activity
    °ñ Ȱ¼º
  • chemotactic activity
    È­ÇÐ ÁÖ¼º´É
  • concomitant activity
    µ¿¹Ý Ȱµ¿, ºÎ¼öÀû È¿°ú
  • diurnal activity
    ÁÖ°£ ÀÌ»ó ±â´É Ȱµ¿
  • efferent activity
    ¿ø½É Ȱ¼º
  • efferent sympathetic activity
    ¿ø½É ±³°¨½Å°æ Ȱ¼º
  • electrical activity
    Àü±âÀû Ȱ¼º
  • fidgeting activity
    ¾ÈÀýºÎÀýÇϴ Ȱµ¿
  • helper cell activity
    ÇïÆÛ ¼¼Æ÷ Ȱ¼º
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
fibrinolytic Pertaining to, characterised by or causing the dissolution of fibrin by enzymatic action
Origin: Gr. Lysis = dissolution
(18 Nov 1997)
fibrinolytic agent Fibrinolysin or agents that convert plasminogen to fibrinolysin. They may be endogenous or exogenous like the bacterial enzymes used in thromboembolism.
(12 Dec 1998)
fibrinolytic purpura Purpura in which the bleeding is associated with rapid fibrinolysis of the clot.
(05 Mar 2000)
activity 1. The state of being active, the ability to produce some effect, the extent of some function or action.
2. <chemistry> A thermodynamic quantity that represents the effective concentration of a solute in a nonideal solution, if concentrations are replaced by activities, the equations for equilibrium constants, electrode potentials, osmotic pressure, boiling point elevation, freezing point depression and vapour pressures of volatile solutes are converted from approximations that hold only for dilute solutions to exact equations that hold for all concentrations. The activity is equal to the product of the concentration and the activity coefficient, a dimensionless number measuring deviation from nonideality. Symbol a.
The potential or true thermodynamic activity of a substance, as opposed to its molar concentration.
3. <radiobiology> The number of nuclear transitions or disintegrations occurring in a given quantity of radioactive material per unit time. The SI unit of activity is s-1. The special name for the unit of activity is becquerel (Bq). The previously used special unit of activity, curie (Ci), is being replaced by the becquerel. 1 Bq = 2.7 x E-11 Ci. 1 Ci = 3.7 x E10 Bq.
4. Optical activity.
(16 Dec 1997)
activity coefficient <chemistry> The factor by which the value of a concentration of a solute must be multiplied to determine its true thermodynamic activity.
(06 May 1997)
activity cycles Bouts of physical irritability or movement alternating with periods of quiescence. It includes biochemical activity and hormonal activity which may be cellular. These cycles are shorter than 24 hours and include sleep-wakefulness cycles and the periodic activation of the digestive system.
(12 Dec 1998)
activity, drug A measure of the physiological response a drug produces in the body. A less active drug produces less response (and visa versa).
(12 Dec 1998)
blocking activity The repression or elimination of electrical activity in the brain by the arrival of a sensory stimulus.
(05 Mar 2000)
blood bactericidal activity Native bactericidal property of blood due to normally occurring antibacterial substances such as beta lysin, leukin, etc.
(12 Dec 1998)
melanoma growth stimulatory activity Cytokine of the C X C subfamily. Potent mitogen. Activates and is chemotactic for, neutrophils.
(18 Nov 1997)
water activity <chemistry> An expression of the relative availability of water in a substance. Pure water has an water activity of 1.000. The water activity of a solution is one-hundredth its relative humidity.
(09 Oct 1997)
motor activity The physical activity of an organism as a behavioural phenomenon.
(12 Dec 1998)
complement haemolytic activity assay Usual screening assay for complement. Dilutions of the serum to be tested are added to antibody-coated erythrocytes and the percentage of lysis is measured. The values are expressed by ch50, haemolytic complement units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay.
(12 Dec 1998)
plasma renin activity The estimation of renin in plasma by measuring the rate of formation of angiotensin I or II.
(05 Mar 2000)
solar activity Any type of variation in the appearance of energy output of the sun.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • activity
    Ȱµ¿,Ȱ±â
  • activity
    Ȱµ¿;Ȱ¾à;Ȱ±â;ȰȲ;´Éµ¿¼º;Ȱµ¿¹üÀ§
  • crew activity planning
    (¿ìÁÖ¼± ºñÇàÁßÀÇ) ½Â¹«¿ø ÀÛ¾÷°èȹ
  • extracurricular activity
    °ú¿Ü Ȱµ¿;(¼Ó)ºÎÁ¤(ºÎµµ´ö)ÇàÀ§;¿Üµµ
  • extravehicular activity
    (¿ìÁÖÀÎÀÇ)¼±¿Ü Ȱµ¿
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á